Sotera Health (NASDAQ:SHC) Stock Holdings Lowered by Bank of America Corp DE

Bank of America Corp DE lowered its position in shares of Sotera Health (NASDAQ:SHC - Free Report) by 76.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 101,020 shares of the company's stock after selling 335,907 shares during the period. Bank of America Corp DE's holdings in Sotera Health were worth $1,382,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of SHC. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after purchasing an additional 1,140 shares during the period. Empowered Funds LLC acquired a new stake in Sotera Health during the 4th quarter worth about $351,000. Entropy Technologies LP acquired a new position in shares of Sotera Health in the 4th quarter valued at about $229,000. New York State Teachers Retirement System increased its holdings in shares of Sotera Health by 8.7% in the 4th quarter. New York State Teachers Retirement System now owns 58,173 shares of the company's stock valued at $796,000 after purchasing an additional 4,673 shares during the period. Finally, Rhumbline Advisers raised its position in Sotera Health by 3.8% during the fourth quarter. Rhumbline Advisers now owns 399,171 shares of the company's stock valued at $5,461,000 after acquiring an additional 14,616 shares in the last quarter. Institutional investors own 91.03% of the company's stock.

Sotera Health Stock Performance

SHC opened at $12.19 on Friday. The firm has a market cap of $3.46 billion, a P/E ratio of 48.76 and a beta of 1.87. Sotera Health has a 52-week low of $9.53 and a 52-week high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business's fifty day moving average is $11.72 and its 200-day moving average is $12.56.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. The firm had revenue of $254.52 million for the quarter, compared to analysts' expectations of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.13 earnings per share. Sell-side analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on SHC. Barclays lowered their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Finally, Piper Sandler cut their price target on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.